Latest in Ophthalmology

Reuters Health • The Doctor's Channel Daily Newscast

Visual field extent not reduced much by early treatment of ROP

NEW YORK (Reuters Health) – Treating high-risk retinopathy of prematurity (ROP) early, before threshold severity is reached, preserves peripheral vision with relatively little reduction in visual field extent. That’s according to a report from the Early Treatment for Retinopathy of Prematurity...

Reuters Health • The Doctor's Channel Daily Newscast

Dual-focus contact lenses slow myopia progression in childhood

NEW YORK (Reuters Health) – Results of an early phase trial indicate that wearing an experimental dual-focus soft contact lens can reduce myopia progression in children, according to a New Zealand team. Dr. John R. Phillips and Dr. Nicola S. Anstice at the University of Auckland explain in...

Reuters Health • The Doctor's Channel Daily Newscast

High-dose IV glucocorticoids effective for Graves’ orbitopathy but care warranted

NEW YORK (Reuters Health) – The response rate to high-dose pulsed intravenous glucocorticoid therapy is about 80% for patients with active Graves’ orbitopathy, German clinicians report. However, they caution that potential for major adverse effects necessitates careful patient selection. Writing in the...

Treatment for Grave’s eye disease

MRI improvements for eye imaging

Strabismus

Lateral eye pulley popping

Eye muscles and vision

Uveual melanoma treatment

Double vision

Graves’ Eye Disease and IGF-1

Fluoroquinolones linked to diplopia

Losing an eye – how to treat

Cosmeceuticals and eyelash growth

Thyroid eye disease referral

Lasik surgery and cataract surgery

Uveal melanoma